Stay updated on Fisogatinib in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page
- CheckyesterdayChange DetectedA funding attribution line '2015 ( U.S. NIH Grant/Contract )' was added to the study's records. The site revision tag was updated to 'Revision: v3.6.6' (replacing the previous 'v3.6.5').SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now displays Revision: v3.6.5 instead of v3.6.4, indicating a small site update reflected in the page footer/metadata.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page footer now shows Revision: v3.6.4, replacing the previous v3.6.3. This indicates a software/template version update for the page without altering the study content.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3 on the page. This reflects a minor platform build update and does not modify study information or patient-facing content.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision label on the page updated from v3.6.0 to v3.6.2, indicating a minor platform update. The page's study details and listed locations remain unchanged.SummaryDifference0.0%

- Check80 days agoChange DetectedRecruitment status now indicates recruitment is closed. The page adds help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment header formatting, along with a revision footer change from v3.5.5 to v3.6.0.SummaryDifference0.3%

Stay in the know with updates to Fisogatinib in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page.